New catheter aims to save limbs when all else fails
NCT ID NCT06311773
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This study tests a device called the Boomerang Catheter in 120 people with chronic limb-threatening ischemia (CLTI), a severe condition where blocked leg arteries can lead to amputation. The catheter creates a connection between a vein and an artery to reroute blood around the blockage. The main goal is to see if this procedure helps patients avoid amputation or death within 6 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Boomerang Catheter
- What this could lead to
- If successful, this device could offer a new way to save limbs and improve survival for people with severe leg artery blockages who have no other treatment options.
- What could go wrong
- This is an early-stage trial with only 120 participants and no comparison group, so results may not apply to everyone. Risks include procedural complications like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIMB-THREATENING ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Vascular Centers
Tigard, Oregon, 97223, United States
-
American Endovascular and Amputation Prevention
West Orange, New Jersey, 07052, United States
-
Arrowhead Regional Medical Center
San Bernardino, California, 92324, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Cardiovascular Institute of the South
Houma, Louisiana, 70360, United States
-
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
EndoVascular Consultants
Wilmington, Delaware, 19805, United States
-
First Coast Cardiovascular Institute
Jacksonville, Florida, 32256, United States
-
HOPE Vascular and Podiatry
Houston, Texas, 77054, United States
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, California, 90502, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Northwell Health - Lake Success
Lake Success, New York, 11042, United States
-
Olive View-UCLA Medical Center
Sylmar, California, 91342, United States
-
PIH Whittier Hospital
Whittier, California, 90602, United States
-
Penn Medicine
Philadelphia, Pennsylvania, 19104, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Spartanburg Regional Medical Center
Spartanburg, South Carolina, 29303, United States
-
St. Luke's University Hospital
Bethlehem, Pennsylvania, 18015, United States
-
Sunrise Vascular
Murphy, North Carolina, 28906, United States
-
UT Southwestern Medical Center
Dallas, Texas, 75235, United States
-
University of Washington Medicine
Seattle, Washington, 98133, United States
-
VIC Vascular Institute
Chattanooga, Tennessee, 37421, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Vascular Institute at AMI
Galloway, New Jersey, 08205, United States
-
Weill Cornell Medical Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sound wave camera inside arteries save more legs?
- Can frailty predict stent failure? new study investigates
- New balloon coated with drug could save limbs in severe artery disease
- New ultrasound technique aims to save limbs in artery disease patients
- Blood thinner duration trial aims to save limbs in severe artery disease
- New device aims to prevent amputation in patients with no other options